Clinical Trial Detail

NCT ID NCT03017820
Title VSV-hIFNbeta-NIS in Treating Patients With Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia, or T-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mayo Clinic
Indications

multiple myeloma

anaplastic large cell lymphoma

acute myeloid leukemia

lymphoma

angioimmunoblastic T-cell lymphoma

peripheral T-cell lymphoma

cutaneous T cell lymphoma

Therapies

VSV-hIFNbeta-NIS

Age Groups: adult senior

No variant requirements are available.